Naturally processed class II epitope from the tumor antigen MUC1 primes human CD4+ T cells.

Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size

1992 • 763 citations

Peptides Presented to the Immune System by the Murine Class II Major Histocompatibility Complex Molecule I-A _d

1992 • 654 citations

Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells.

1989 • 453 citations

Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells.

1991 • 353 citations

Humoral immunity against a tandem repeat epitope of human mucin MUC-1 in sera from breast, pancreatic, and colon cancer patients.

1994 • 307 citations

Induction of HLA-A2-restricted CTLs to the mucin 1 human breast cancer antigen.

1997 • 142 citations

HLA-DR3 molecules can bind peptides carrying two alternative specific submotifs.

1994 • 89 citations

Human Tumor Antigens Are Ready to Fly

1996 • 85 citations

Motifs and supermotifs for MHC class II binding peptides.

1995 • 57 citations